CU23034A3 - Procedimiento para plegar polipeptidos sintetizados quimicamente. - Google Patents

Procedimiento para plegar polipeptidos sintetizados quimicamente.

Info

Publication number
CU23034A3
CU23034A3 CU20030094A CU20030094A CU23034A3 CU 23034 A3 CU23034 A3 CU 23034A3 CU 20030094 A CU20030094 A CU 20030094A CU 20030094 A CU20030094 A CU 20030094A CU 23034 A3 CU23034 A3 CU 23034A3
Authority
CU
Cuba
Prior art keywords
polypeptides
synthetiated
procedure
folding
chemically
Prior art date
Application number
CU20030094A
Other languages
English (en)
Inventor
Antonio Verdini
Giampietro Corradin
Mario Roggero
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of CU23034A3 publication Critical patent/CU23034A3/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CU20030094A 2000-11-27 2001-11-27 Procedimiento para plegar polipeptidos sintetizados quimicamente. CU23034A3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204207 2000-11-27
PCT/EP2001/014163 WO2002050099A2 (en) 2000-11-27 2001-11-27 Process for folding chemically synthesized polypeptides

Publications (1)

Publication Number Publication Date
CU23034A3 true CU23034A3 (es) 2005-03-22

Family

ID=8172340

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20030094A CU23034A3 (es) 2000-11-27 2001-11-27 Procedimiento para plegar polipeptidos sintetizados quimicamente.

Country Status (22)

Country Link
US (2) US20020082384A1 (es)
EP (2) EP1679318A1 (es)
JP (1) JP2004516300A (es)
KR (1) KR20030081315A (es)
CN (2) CN1249078C (es)
AT (1) ATE322501T1 (es)
AU (2) AU2002229603B2 (es)
BR (1) BR0113091A (es)
CA (1) CA2416054A1 (es)
CU (1) CU23034A3 (es)
DE (1) DE60118598T2 (es)
DK (1) DK1337549T3 (es)
ES (1) ES2261509T4 (es)
HU (1) HUP0302395A3 (es)
IL (1) IL155506A0 (es)
MX (1) MXPA03003576A (es)
NO (1) NO20032356D0 (es)
NZ (1) NZ523679A (es)
PL (1) PL364932A1 (es)
RU (1) RU2275377C2 (es)
WO (1) WO2002050099A2 (es)
ZA (1) ZA200300642B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
EP1615945B1 (en) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
US9005625B2 (en) 2003-07-25 2015-04-14 Novo Nordisk A/S Antibody toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
EP1807442A1 (en) * 2004-10-26 2007-07-18 Lonza Ag S-alkyl-sulphenyl protection groups in solid-phase synthesis
US20080176790A1 (en) 2004-10-29 2008-07-24 Defrees Shawn Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf)
US9029331B2 (en) 2005-01-10 2015-05-12 Novo Nordisk A/S Glycopegylated granulocyte colony stimulating factor
US20070154992A1 (en) 2005-04-08 2007-07-05 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP1893632B1 (en) * 2005-06-17 2015-08-12 Novo Nordisk Health Care AG Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US20090081145A1 (en) * 2005-12-23 2009-03-26 Aplagen Gmbh Process for forming disulphide bridges
AU2007248855A1 (en) * 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
US20080242607A1 (en) 2006-07-21 2008-10-02 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
US20100075375A1 (en) 2006-10-03 2010-03-25 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
WO2008077621A1 (de) * 2006-12-23 2008-07-03 Aplagen Gmbh Verfahren zur ausbildung von disulfidbrücken
KR20100016160A (ko) 2007-04-03 2010-02-12 바이오제너릭스 에이지 글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법
MX2009013259A (es) 2007-06-12 2010-01-25 Novo Nordisk As Proceso mejorado para la produccion de azucares de nucleotidos.
US20130189239A1 (en) 2008-02-27 2013-07-25 Novo Nordisk A/S Conjugated Factor VIII Molecules
CN104844693B (zh) * 2015-06-10 2018-08-03 成都圣诺生物科技股份有限公司 一种合成利那洛肽的方法
CN111655314B (zh) 2018-02-02 2022-11-18 诺和诺德股份有限公司 具有可偏转换能器的药物注射装置
CN111100188A (zh) * 2018-10-25 2020-05-05 成都医学院 一种制备蜘蛛抗菌肽的方法
CN109593119A (zh) * 2019-01-27 2019-04-09 上海丽珠制药有限公司 一种[2-d-组氨酸]-醋酸亮丙瑞林的制备方法
JP7453745B2 (ja) * 2019-03-28 2024-03-21 株式会社ヤクルト本社 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法
CN110845595A (zh) * 2019-11-14 2020-02-28 连云港职业技术学院 一种固相合成5-tmara标记的铁调素-25的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
DE3236849A1 (de) * 1982-10-05 1984-04-05 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue thiohydrazin-1,2-dicarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
CN1105029A (zh) * 1993-05-24 1995-07-12 花王株式会社 制备溶解蛋白质的方法
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
DE4431317A1 (de) * 1994-09-02 1996-03-07 Biotechnolog Forschung Gmbh Schutz- bzw. Ankergruppen und deren Verwendung

Also Published As

Publication number Publication date
US20050239162A1 (en) 2005-10-27
ES2261509T4 (es) 2008-02-16
RU2275377C2 (ru) 2006-04-27
CN1249078C (zh) 2006-04-05
ATE322501T1 (de) 2006-04-15
DK1337549T3 (da) 2006-07-31
NO20032356L (no) 2003-05-26
HUP0302395A2 (hu) 2003-10-28
CA2416054A1 (en) 2002-06-27
ZA200300642B (en) 2004-07-16
DE60118598D1 (de) 2006-05-18
WO2002050099A2 (en) 2002-06-27
US20020082384A1 (en) 2002-06-27
JP2004516300A (ja) 2004-06-03
DE60118598T2 (de) 2007-02-15
ES2261509T3 (es) 2006-11-16
EP1337549B1 (en) 2006-04-05
NZ523679A (en) 2005-10-28
KR20030081315A (ko) 2003-10-17
BR0113091A (pt) 2003-07-08
CN1449406A (zh) 2003-10-15
MXPA03003576A (es) 2003-10-14
HUP0302395A3 (en) 2007-05-02
AU2002229603B2 (en) 2007-11-08
EP1337549A2 (en) 2003-08-27
AU2960302A (en) 2002-07-01
NO20032356D0 (no) 2003-05-26
CN1830999A (zh) 2006-09-13
PL364932A1 (en) 2004-12-27
EP1679318A1 (en) 2006-07-12
IL155506A0 (en) 2003-11-23
WO2002050099A3 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
CU23034A3 (es) Procedimiento para plegar polipeptidos sintetizados quimicamente.
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
BR0108164A (pt) Uso de pelo menos uma protease estável em ácido, processo para melhorar o valor nutritivo de um alimento para animal, aditivo de alimento para animal, composição de alimento para animal, e, processo para tratar proteìnas vegetais
ATE274884T1 (de) Künstliches fingergelenk
DK0996459T3 (da) Anvendelse af exendiner og agonister deraf til reduktion af födeindtagelse
DK1068241T3 (da) Antistofvarianter og fragmenter deraf
IL161016A (en) Polypeptides capable of ang-2 binding
DE60134251D1 (de) Verwendung von glp-2-peptiden
BR9714505A (pt) para o diabetes.
ES2062812T3 (es) Composicion detergente enzimatica y metodo para estabilizar enzimas.
NO20025355L (no) Farmasöytisk preparat som omfatter en faktor VIIA og en faktor XIII
PT94633A (pt) Metodo para a desnaturacao oxidante de analitos de proteina
EP1350846A4 (en) C-TERMINAL MODIFIED PROTEIN AND METHOD FOR THE PRODUCTION THEREOF, IN THE PREPARATION OF C-TERMINAL MODIFIED PROTEIN TO BE USED, AND TRANSLATION TEMPLATE AND METHOD FOR DETECTING PROTEIN CHANGING EFFECT USING THE C-TERMINAL MODIFIED PROTEIN
BR9709569B1 (pt) processo para ativação de proteìna desnaturada.
NO20026128L (no) Gelformet drivstoff, fremgangsmåte for dets fremstilling og dets anvendelse
BR9911891A (pt) Proteases fundidas com variantes de inibidor de subtilisina de streptomyces
DE60222759D1 (de) Proteinsyntheseverfahren mit zellfreiem proteinsynthesesystem
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60220658D1 (de) Verfahren zur produktion von 2,6-dihalogenopurinen
DE3852105T2 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
DE602004027039D1 (de) Cytokinpolypeptidvarianten
DE69736325D1 (de) Cr1 fragmente und deren verwendung
EP1385979A4 (en) METHOD FOR IMPROVING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
DK1325000T3 (da) Thiazoldiendionderivat og dets anvendelse som antidiabetisk middel